1. Home
  2. TECH vs LNTH Comparison

TECH vs LNTH Comparison

Compare TECH & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bio-Techne Corp

TECH

Bio-Techne Corp

HOLD

Current Price

$57.11

Market Cap

9.5B

Sector

Health Care

ML Signal

HOLD

Logo Lantheus Holdings Inc.

LNTH

Lantheus Holdings Inc.

HOLD

Current Price

$65.09

Market Cap

4.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TECH
LNTH
Founded
1976
1956
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.5B
4.4B
IPO Year
1989
2015

Fundamental Metrics

Financial Performance
Metric
TECH
LNTH
Price
$57.11
$65.09
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
14
6
Target Price
$71.23
$77.67
AVG Volume (30 Days)
1.8M
1.1M
Earning Date
02-04-2026
11-06-2025
Dividend Yield
0.56%
N/A
EPS Growth
N/A
N/A
EPS
0.49
2.39
Revenue
$1,216,732,000.00
$1,525,933,000.00
Revenue This Year
$2.33
$0.01
Revenue Next Year
$7.05
$1.24
P/E Ratio
$117.08
$27.26
Revenue Growth
3.85
1.95
52 Week Low
$46.01
$47.25
52 Week High
$79.28
$111.29

Technical Indicators

Market Signals
Indicator
TECH
LNTH
Relative Strength Index (RSI) 38.72 66.71
Support Level $56.59 $60.15
Resistance Level $61.20 $67.01
Average True Range (ATR) 2.00 2.15
MACD -0.63 0.41
Stochastic Oscillator 6.35 79.06

Price Performance

Historical Comparison
TECH
LNTH

About TECH Bio-Techne Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

About LNTH Lantheus Holdings Inc.

Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.

Share on Social Networks: